Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.001
+0.001 (0.10%)
Apr 1, 2025, 10:42 AM EDT - Market open

Cytosorbents Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
35.5936.3534.6943.1741
Upgrade
Revenue
35.5936.3534.6943.1741
Upgrade
Revenue Growth (YoY)
-2.08%4.79%-19.64%5.27%64.35%
Upgrade
Cost of Revenue
10.4713.9613.9611.0511.05
Upgrade
Gross Profit
25.1322.3920.7332.1229.95
Upgrade
Selling, General & Admin
3536.9436.538.4831.51
Upgrade
Research & Development
6.9215.7315.1216.388.81
Upgrade
Operating Expenses
41.9152.6751.6254.8640.32
Upgrade
Operating Income
-16.79-30.27-30.89-22.74-10.37
Upgrade
Interest Expense
-1.4-0.16---1.2
Upgrade
Interest & Investment Income
--0.130.03-
Upgrade
Currency Exchange Gain (Loss)
-4.221.95-2.45-2.582.61
Upgrade
Other Non Operating Income (Expenses)
-00.1-0.07--
Upgrade
EBT Excluding Unusual Items
-22.41-28.39-33.27-25.29-8.96
Upgrade
Asset Writedown
--0.66-0.64--
Upgrade
Legal Settlements
--0.28---
Upgrade
Pretax Income
-22.41-29.32-33.91-25.29-8.96
Upgrade
Income Tax Expense
-1.69-0.81-1.09-0.74-1.13
Upgrade
Net Income
-20.72-28.51-32.81-24.56-7.84
Upgrade
Net Income to Common
-20.72-28.51-32.81-24.56-7.84
Upgrade
Shares Outstanding (Basic)
5445444339
Upgrade
Shares Outstanding (Diluted)
5545444339
Upgrade
Shares Change (YoY)
22.10%2.49%0.49%11.70%20.35%
Upgrade
EPS (Basic)
-0.38-0.64-0.75-0.57-0.20
Upgrade
EPS (Diluted)
-0.38-0.64-0.75-0.57-0.20
Upgrade
Free Cash Flow
-14.71-22.19-34.32-17.65-6.32
Upgrade
Free Cash Flow Per Share
-0.27-0.50-0.79-0.41-0.16
Upgrade
Gross Margin
70.59%61.60%59.77%74.41%73.05%
Upgrade
Operating Margin
-47.16%-83.28%-89.04%-52.69%-25.29%
Upgrade
Profit Margin
-58.21%-78.43%-94.59%-56.89%-19.11%
Upgrade
Free Cash Flow Margin
-41.33%-61.06%-98.94%-40.88%-15.42%
Upgrade
EBITDA
-15.22-28.81-30-22.01-9.71
Upgrade
EBITDA Margin
-42.75%-79.26%-86.49%-51.00%-23.68%
Upgrade
D&A For EBITDA
1.571.460.880.730.66
Upgrade
EBIT
-16.79-30.27-30.89-22.74-10.37
Upgrade
EBIT Margin
-47.16%-83.28%-89.04%-52.69%-25.29%
Upgrade
Revenue as Reported
-36.3534.6943.1741
Upgrade
Advertising Expenses
-0.250.580.620.29
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q